Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT06848140
RecruitingNCT06848140ClinicalTrials.gov record

Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury

Traumatic Brain Injury · Word Finding Difficulty · Cognitive Symptom · Cognitive Change · Acquired Brain Injury

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Not applicable
Age range
18 years - 85 years
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
14 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The purpose of this study is to learn more about how brain stimulation affects word finding problems in people who have a traumatic brain injury (TBI). The type of brain stimulation used is called transcranial direct current stimulation (tDCS). tDCS delivers low levels of electric current to the brain and high definition tDCS (HD-tDCS) delivers the current with multiple electrodes on the scalp. This current is delivered with HD-tDCS to parts of the brain that may help with remembering things. The investigators hope that this can help to improve word finding and memory problems in people with TBI.

Read the full description

The investigators plan to recruit English-speaking participants aged 18-85 years with a history of chronic TBI (\> 1 year since injury prior to enrollment), all of whom have problems with cognition. The participants will be randomized to receive (1) active first followed by sham HD-tDCS condition, or (2) sham first followed by active condition in order to assess the efficacy of HD-tDCS on improving verbal retrieval function. The randomization will be double-blinded to the participants and the research personnel who administer the procedures. The study therefore adopts a double-blind randomized cross-over design. The proposed study will measure response to HD-tDCS treatment over the pre-supplementary motor area (preSMA) region when compared to sham with verbal retrieval function (verbal fluency, naming, verbal learning) as the primary outcome. Secondary outcome measures include cognitive performance other than verbal retrieval function and electroencephalography (EEG) measures. The participants will receive two phases of 10 sessions of active stimulation (1 mA anodal HD-tDCS targeting preSMA for 20 min) or sham across 2 weeks. All participants will be blinded to their condition. EEG and neuropsychological tasks will be completed at baseline, immediate follow-up after session 10, and a 2-month follow-up. The participants will also undergo an MRI session at baseline. Those participants randomized into the active or sham group will have the opportunity to return after 2 months and receive sham (if active first) or active (if sham first) treatment and will undergo the EEG and neuropsychological tests again immediately following the last HD-tDCS session and at a 2-month follow-up.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Age between 18 and 85
  • Fluent in speaking and reading English
  • Able to provide informed consent
  • Has a TBI at least one year prior to enrollment and not related to military experience
  • Has a confirmation of verbal retrieval difficulties as measured by the Verbal Retrieval Difficulty Interview questions

Exclusion Criteria:

  • Lifetime major or active neurologic conditions (e.g., stroke, epilepsy, brain tumor, dementia, seizure occurrence less than one year ago)
  • Lifetime major or active cardiovascular conditions (e.g., cardiac arrythmia, heart failure, heart attack)
  • Current substance use disorder
  • Lifetime major psychiatric disorders (e.g., schizophrenia, bipolar disorder)
  • Severe depression at the time of enrollment (BDI-II \>= 29) or psychiatric ER visits or hospitalization less than 6 months ago prior to enrollment
  • Current sensory (e.g., blind, deaf) or physical (e.g., severe motor weakness) impairment that interferes with testing
  • Contraindications for tDCS or MRI
  • The person cannot be left alone for 8+ hours.
  • Not verbally communicative.
  • Currently undergoing and not wishing to discontinue speech and cognitive therapy during study participation.
  • Incapable of understanding the consent or unable to consent for oneself.
  • Unable to travel to BIDMC's Berenson-Allen Center
  • Pregnancy
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Random assignment
Masking
Triple masked
Active to Sham Transcranial direct current stimulation

Subjects in this arm will first be randomly assigned to receive active stimulation. After completion of active stimulation, subjects will be assigned to sham stimulation.

Device: Active Transcranial direct current stimulation · Device: Sham Transcranial direct current stimulation

Sham to Active transcranial direct current stimulation

Subjects in this arm will first be randomly assigned to receive sham stimulation. After completion of sham stimulation, subjects will be assigned to active stimulation.

Device: Active Transcranial direct current stimulation · Device: Sham Transcranial direct current stimulation

Active Transcranial direct current stimulation DEVICE

Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim 20 or 32. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.

Sham Transcranial direct current stimulation DEVICE

Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim 20 or 32. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

The Controlled Oral Word Association Test - letter fluency

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Control Word Association Test. Metric: Number of Correct Items Generated

The Controlled Oral Word Association Test - category fluency

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on Category Fluency. Metric: Number of Correct Items Generated

The Boston Naming Test

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on The Boston Naming Test. Metric: Number of Correct Items Generated.

The Delis Kaplan Color Word Interference Test

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Delis Kaplan Color Word Interference Test. Metric: Time to Name Items

Rey Auditory Verbal Learning Test and alternative lists

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Rey Auditory Verbal Learning Test. Metric: Number of Total learning items and Correct Recalls.

Secondary measures

The Trail Making Test (Parts A & B)

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Trail Making Test (Parts A\&B). Metric: Time to Solution

Digit Span Forward & Backward

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Digit Span Forward \& Backward. Metric: Memory Span

Rey-Osterrieth Complex Figure Test

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Rey-Osterrieth Complex Figure Test scores. Metric: Score

The Digit Symbol Substitution Test

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Digit Symbol Substitution Test. Metric: Number of Items

Task-based electroencephalography (EEG) markers during a Go-NoGo task

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in EEG change on a Go-NoGo task with different levels of perceptual/semantic complexity. Metric: event-related potentials and time frequency changes.

Task-based electroencephalography (EEG) markers during a Semantic Object Memory Retrieval task

Time frame: Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in EEG change on a Semantic Object Retrieval task. Metric: event-related potentials and time frequency changes.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Beth Israel Deaconess Medical CenterBoston, Massachusetts, United StatesRecruiting

Study team and timeline

Lead sponsor
Beth Israel Deaconess Medical Center
Study start
Oct 1, 2025 Actual
Primary completion
Apr 30, 2028 Estimated
Study completion
Apr 30, 2028 Estimated
First posted
Feb 26, 2025 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Hsueh-Sheng Chiang, MD, PhDCONTACThchiang3@bidmc.harvard.edu
Official study title

Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026